Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Radiation Dose Hypofractionation × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Specimen Handling 4 Nivolumab 4 Biopsy 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Immunoglobulin G 2 Bevacizumab 2 talimogene laherparepvec 1 sargramostim 1 regorafenib 1 prednylidene 1 deltacortene 1 decitabine and cedazuridine drug combination 1 avelumab 1 atezolizumab 1 aflibercept 1 X-Rays 1 Sirolimus 1 Radiosurgery 1 Prednisone 1 Paclitaxel 1 NEO212 1 MAPRE1 protein, human 1 Lidocaine, Prilocaine Drug Combination 1 IFL protocol 1 Disulfides 1 Cyclophosphamide 1 Colony-Stimulating Factors 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡